Minerva Neurosciences Inc
F:4MNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Minerva Neurosciences Inc
F:4MNA
|
US |
|
L
|
Lloyds Banking Group PLC
XHAM:LLD
|
UK |
|
W
|
WiseTech Global Ltd
F:17W0
|
AU |
|
Cyclone Metals Ltd
F:HM5
|
AU |
|
S
|
Swire Properties Ltd
F:SW9
|
HK |
|
Oric Pharmaceuticals Inc
F:4TZ
|
US |
|
C
|
Canadian Natural Resources Ltd
XMUN:CRC
|
CA |
|
B
|
Bayer AG
XMUN:BAYN
|
DE |
|
H
|
Hargreaves Lansdown PLC
SWB:DMB
|
UK |
|
A
|
Alarm.com Holdings Inc
SWB:3RL
|
US |
|
B
|
BCI Minerals Ltd
OTC:BIRNF
|
AU |
|
T
|
Toromont Industries Ltd
F:14T
|
CA |
|
Livingstone Health Holdings Ltd
SGX:PRH
|
SG |
|
Eventbrite Inc
NYSE:EB
|
US |
|
FormPipe Software AB
F:F3J
|
SE |
|
C
|
CNOOC Ltd
DUS:NC2B
|
CN |
|
Q
|
Q2 Holdings Inc
F:0Q2
|
US |
|
A
|
AMP Ltd
XBER:AMP
|
AU |
Wall St Price Targets
4MNA Price Targets Summary
Minerva Neurosciences Inc
According to Wall Street analysts, the average 1-year price target for
4MNA is 7.06 EUR with a low forecast of 5.151 EUR and a high forecast of 10.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4MNA's stock price target?
Price Target
7.06
EUR
According to Wall Street analysts, the average 1-year price target for
4MNA is 7.06 EUR with a low forecast of 5.151 EUR and a high forecast of 10.71 EUR.
What is the Net Income forecast for Minerva Neurosciences Inc?
Projected CAGR
103%
The compound annual growth rate for Net Income over the next 7 years is 103%.